Focus

AstraZeneca to manufacture cancer killer in Singapore

AstraZeneca aims to begin design and construction of the manufacturing facility by the end of this year.

20 May 2024 03:52pm
Photo for illustrative purposes only - 123RF
Photo for illustrative purposes only - 123RF

SINGAPORE - AstraZeneca will invest US$1.5 billion in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs), the biopharmaceutical giant announced Monday.

AstraZeneca aims to begin design and construction of the manufacturing facility by the end of this year, with targeted operational readiness from 2029, reported Xinhua.

ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody, according to the company. - BERNAMA-XINHUA

Related Articles:
antibody drug
AstraZeneca
Singapore
cancer
healthcare
health
More Like This
Photo for illustrative purposes only - Canva
Photo for illustrative purposes only - Canva
World One dead, one injured in Australian helicopter crash
The two men were travelling in an US-registered Super Puma helicopter when it crashed shortly before midday.
Photo for illustration purposes only.
Photo for illustration purposes only.
World Singapore hangs third drug trafficker in a week
The hanging at Changi prison followed the Nov 15 execution of two men -- a 39-year-old Malaysian and a 53-year-old Singaporean -- also for drug trafficking.
A chimpanzee is pictured at the Pridadomus recovering centre in Villena, near Alicante. AFP FILE PIX
A chimpanzee is pictured at the Pridadomus recovering centre in Villena, near Alicante. AFP FILE PIX
World Chimps are upping their tool game, says study
"Planet of the Apes" may have been onto something.
US President-elect Donald Trump is handing top roles in his future administration to a mix of allies, provocateurs and a few relatively conventional figures. - (Photo by various sources / AFP)
US President-elect Donald Trump is handing top roles in his future administration to a mix of allies, provocateurs and a few relatively conventional figures. - (Photo by various sources / AFP)
World Trump's top team: Firebrands and stalwarts
WASHINGTON - US President-elect Donald Trump is handing top roles in his future administration to a mix of allies, provocateurs and a few relatively conventional figures. Most positions require Senate approval, which brings added scrutiny. Here is who Trump has chosen so far: - Health Secretary:...